Trade HUMA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Humacyte, Inc. (HUMA) is trading at US$0.43, down 2.39% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$178.4M. Over the past 52 weeks, HUMA has traded between US$0.34 and US$1.90. On Syfe you can trade HUMA with $0 commission and add it to your watchlist.
| Previous close | US$0.44 |
|---|---|
| Market cap | US$178.4M |
| 52-week range | US$0.34 – US$1.90 |
| Volume | 5.94M |
| Exchange | US |
Humacyte, Inc.
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Year: 2021
Humacyte Gets US FDA Clearance to Extend Symvess Shelf Life to 36 Months
Sep 9, 1:31 PM · MT Newswires
Humacyte Plans FDA Filing for Acellular Tissue Engineered Vessel in Dialysis Access
Aug 24, 12:52 PM · MT Newswires
Humacyte Says US FDA Accepted IND for Human Trial of Coronary Tissue Engineered Vessel in Surgery
Jul 27, 12:54 PM · MT Newswires
Humacyte Says ATEV Met Late-Stage Study Endpoint in Interim Analysis, Launches Public Offering; Shares Fall
Jun 10, 8:51 PM · MT Newswires
Humacyte, Inc. (HUMA) stock is trading at US$0.43, -2.39% from the previous close of US$0.44.
The market cap for Humacyte, Inc. (HUMA) stock is approximately US$178.4M.
The 52-week high for Humacyte, Inc. (HUMA) stock is US$1.90.
The 52-week low for Humacyte, Inc. (HUMA) stock is US$0.34.
Humacyte, Inc. (HUMA) does not currently pay a dividend.
Stay on top of HUMA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
